Abstract

Myzithra whey cheese was made by the addition of ovine milk (10%) to whey, previously fermented by the bacteriocinogenic strain Streptococcus thermophilus ACA‐DC 0040, resulting in production of a bacteriocin (thermophilin T) titre at a concentration 40 960 ± 2560 AU/mL. The final antimicrobial activity in the ready‐to‐eat cheese was sufficient to inhibit the growth of coliforms and restrict the growth of bacteria of the Micrococcus group, thus contributing to and increased shelf life and the safety of cheese. A lower lactose content was observed in the cheese, which would lead to better acceptance by lactase‐deficient consumers. Moreover, the sensory characteristics of the cheese remained unchanged during the whole cold storage period, ensuring an extended shelf life.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.